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December 20051106 Gröschel et alSecond, several potential risk factors such as coronary
artery disease or chronic obstructive pulmonary disease
were only present in a few patients, so that this study might
have lacked statistical power to adequately determine the
relationship between these variables and the postprocedural
medical complication rate after CAS. This notion is sup-
ported by a recent study that included a large number of
patients with coronary artery disease and found an in-
creased risk for hypotension and bradycardia after CAS in
these patients.14
Third, we did not assess the potential effects of intra-
procedural variables such as episodes of hemodynamic in-
stability on the development of medical complications after
CAS.
CONCLUSION
Life-threatening or fatal non-neurologic complications
after CAS occur in a relatively low proportion of patients.
Older and symptomatic patients are at highest risk, and
these subgroups should be monitoring closely.
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During the last 10 years, carotid artery stenting (CAS) has
evolved into a valuable tool for treating carotid artery stenosis.
After recent approval in the United States, CAS remains with
specific and, at times, limited approval for reimbursement from the
Center for Medicare and Medicaid Services. Regardless, carotid
physicians are continuing to incorporate this valuable new technol-This report from Dr Kastrup provides additional information
about the non-neurologic problems that can be encountered dur-
ing CAS. In a broad sense, one of five patients who undergo CAS
should be expected to have some medical complication, ranging
from myocardial ischemia to hypotension to chest infections. Spe-
cifically, the symptomatic patient and the patient 75 years old
should be considered at higher risk for non-neurologic complica-
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Volume 42, Number 6 Gröschel et al 1107tions after CAS. Although some may be surprised to find such an
incidence, others have reported hemodynamic instability ranging
from 20% to 50% after CAS or any non-neurologic complication at
32.8%.1 However, Kastrup et al may have appropriately selected a
better group of patients for CAS by eliminating those with long or
tandem stenoses or tortuous vessels. This report may then reflect
the value of learning from earlier reports to improve on subsequent
results.
The reader should, however, consider that this report might
be underestimating the total complication rate. The clinical prac-
tice at this German hospital did not include routine cardiac enzyme
surveillance after the procedure as was done in the Stenting and
Angioplasty with Protection in Patients at High Risk for Endarter-
ectomy (SAPPHIRE) study, which recorded a 3.4% incidence of
myocardial infarction. The reader must also consider that access
site complications, such as hematoma, and pseudoaneurysm, are
not included in this series. Finally, the calculation for carotid
stenosis is done by the European Carotid Surgery Trial (ECST)
method (estimating the bulb diameter) rather than the North
American Symptomatic Carotid Endarterectomy Trial (NASCET)
method (using the normal distal internal carotid vessel for refer-ence).2 The degree of stenosis thus may be overestimated and may
confound the results when other contemporary reports are consid-
ered.
Regardless, this report provides the carotid physician with
valuable information when choosing the appropriate method of
revascularization for severe carotid stenosis. Accepting a total
morbidity and mortality of 19.3%, we should balance the other
options of medical therapy and standard carotid endarterectomy
when treating each patient. I would, therefore, encourage all to
continue in support of clinical trials and pursuit of scientific reports
to help the carotid community understand the best therapeutic
option.
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